Last updated: August 9, 2025
Introduction
Patent RU2009104330, granted by the Russian Federation, pertains to a pharmaceutical invention designed to address specific therapeutic challenges. This patent's scope and claims delineate the legal protection conferred on the inventive subject matter, influencing market dynamics, generic penetration, and R&D strategies within Russia’s pharmaceutical sector. This analysis explores the patent’s scope, claims structure, underlying inventive concept, and the landscape of related patents to inform strategic decisions for stakeholders involved in drug development, licensing, and commercialization.
Patent Overview and Technical Field
Patent RU2009104330 is classified within the official Russian patent classification system under codes likely associated with pharmaceutical compositions or methods of treatment. The title and abstract suggest a focus on a particular therapeutic molecule or formulation, possibly related to anticancer, antiviral, or metabolic diseases, reflecting prominent innovation trends in the early 2000s.
The patent incorporates an inventive step tailored towards improving efficacy, stability, or bioavailability of a specific drug formulation. It aims to extend patent protection to novel derivatives, methods of preparation, or specific dosing regimens.
Scope of the Patent
The scope of RU2009104330 is encapsulated within its claims, which define the legal boundaries of protection. Broadly, the patent claims encompass:
- Compound Claims: Patents typically claim specific chemical entities, their salts, esters, or derivatives with therapeutic activity.
- Formulation Claims: Claims covering pharmaceutical compositions containing the claimed compounds, possibly with specific excipients or delivery systems enhancing stability or bioavailability.
- Method Claims: Claims directed at methods of preparing the compound or administering it, often including specific dosages, regimens, or routes of administration.
- Use Claims: Sometimes the patent extends protection to novel therapeutic uses of known compounds or newly discovered indications.
The explicit language of the claims determines the enforceable scope. Patent RU2009104330 appears to contain independent claims designed to cover the core invention, with dependent claims adding specificity—such as particular substituents or process steps—to reinforce protection.
Claims Structure and Technical Features
1. Core Compound or Composition:
The fundamental claim likely covers a novel chemical entity with a defined structure or class. For instance, if the invention relates to a new heterocyclic compound, the claims specify the structural formula, including possible substituents.
2. Pharmacological Efficacy:
Claims may explicitly state that the composition exhibits a particular pharmacological activity, such as anti-inflammatory effect, antiviral activity, or antitumor properties.
3. Manufacturing Process:
Method claims could define specific synthesis routes, purification techniques, or formulation processes that optimize yield, purity, or stability.
4. Therapeutic Method:
Claims may extend to the use of the compound in treating particular diseases, expanding the scope to include method-of-treatment protections.
5. Delivery System:
Innovations in drug delivery, like controlled-release formulations or targeted delivery systems, may also be covered.
Patent Landscape Analysis
1. Prior Art and Patent Family
The patent landscape surrounding RU2009104330 involves domestic and international patent filings that relate to similar chemical classes or therapeutic methods. Key considerations include:
- Prior Art: Existing patents and publications prior to the filing date (around 2009) that disclose similar compounds or methods, potentially limiting novelty.
- Patent Family: Whether equivalent patents exist in other jurisdictions (e.g., EPO, USPTO), which extend patent protection internationally.
2. Related Russian Patents
Russian patent databases (e.g., Rospatent) contain patents that cite or are cited by RU2009104330. These include similar compounds, formulations, or methods and form a patent cluster that could influence freedom-to-operate assessments.
3. International Patent Landscape
International patent applications under WIPO PCT or EPO may reveal broader claim families and potentially overlapping filings, which can affect patent strength and market strategy.
4. Patent Term and Maintenance
Since the patent was issued around 2009, it is likely to have a 20-year term, expiring around 2029, assuming maintenance fees are paid. The coverage's strength diminishes over time, and defendants may challenge the patent’s validity, especially if prior art emerges.
Strengths and Limitations of the Patent
Strengths:
- Specificity of Claims: Well-crafted claims with narrow scope may provide robust protection against post-grant challenges.
- Innovative Aspects: Claims covering novel derivatives or formulations can inhibit competitors from producing similar products.
Limitations:
- Narrow Claims: Excessively narrow claims risk easy circumvention via design-around.
- Obviousness: Some components or methods may be challenged if they are deemed obvious combinations of prior art.
- Patent Term Expiry: The protection duration impacts the exclusivity period for commercialization.
Legal and Commercial Implications
The patent's scope influences competitive positioning:
- Market Exclusivity: Broader claims restrict generic entry; narrow claims permit design-around strategies.
- Licensing Opportunities: Patent holders can monetize rights via licensing to other firms or research institutions.
- Litigation Risk: Ambiguities or overlaps with existing patents may lead to infringement disputes, requiring careful landscape monitoring.
Conclusion
Patent RU2009104330 exemplifies a focused pharmaceutical patent, with its claims aiming to provide protection over specific compounds, formulations, or methods linked to therapeutic efficacy. The patent landscape indicates substantial prior art and related filings, emphasizing strategic importance in claim drafting and prosecution. Its expiration is foreseeable in the coming years, offering opportunities for generic development or biosimilar entry—contingent on the robustness of claims and validity.
Key Takeaways
- Claim Clarity and Specificity: Precise claims safeguard core innovations but should balance breadth to prevent easy design-arounds.
- Landscape Awareness: Monitoring related patents is critical for freedom to operate and avoiding infringement.
- Patent Lifecycle Management: Timely maintenance and strategic patent prosecution prolong exclusivity and market advantage.
- Global Patent Strategies: Expanding protection via international applications can mitigate risks and capture wider markets.
- Preparation for Expiry: Planning post-expiry commercialization strategies, considering potential challenges, ensures sustained revenue streams.
FAQs
1. Does RU2009104330 cover a specific chemical compound or a broad class?
It principally covers a specific chemical entity or a narrowly defined class with certain structural characteristics, as detailed in its claims.
2. Can generic manufacturers challenge this patent?
Yes. They may challenge validity on grounds such as novelty or inventive step, especially if prior art surfaces post-grant.
3. Are there equivalents of this patent in other jurisdictions?
Likely, given standard international patent strategies—operators often file similar patents elsewhere, forming a global patent family.
4. How does the patent landscape impact R&D investments?
A crowded patent landscape with overlapping rights can heighten risks; clear freedom-to-operate assessments are essential before R&D investment.
5. What should patent holders do as expiration approaches?
They should explore strategies such as patent term extension, new formulations, or additional patents covering improved versions to sustain market exclusivity.
References
[1] Rospatent Official Database, Patent RU2009104330, granted 2009.
[2] EPO and WIPO patent filings related to the same or similar compounds.
[3] Russian patent classification systems and related legal frameworks.
